Finny Kuruvilla, MD, PhD

Finny Kuruvilla serves as CIO for Eventide Funds and Portfolio Manager for the Eventide Gilead Fund and the Eventide Healthcare & Life Sciences Fund.

Dr. Kuruvilla has a unique background in healthcare, statistics, and investing. Concurrent with Eventide, from 2008 through 2016, he was a Principal at Clarus Ventures, a leading healthcare and life sciences venture capital firm. Prior to joining Eventide, from 2005-2008, Dr. Kuruvilla was a postdoctoral research scientist in medical genetics at the Broad Institute of Harvard and MIT. From 2003-2007, Dr. Kuruvilla was resident, chief resident, and clinical fellow at the Brigham and Women’s Hospital and Children’s Hospital Boston.

He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry.

News › Finny Kuruvilla, MD, PhD

Mutual funds involve risk including the possible loss of principal. Past performance does not guarantee future results. The Funds’ ethical values screening criteria could cause them to under-perform similar funds that do not have such screening criteria.

Investors should consider a fund’s investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information can be found in the prospectus, which can be obtained at https://www.eventidefunds.com/prospectus or by calling 1-877-771-EVEN (3836). Please read the prospectus carefully before investing. Eventide Mutual Funds are distributed by Northern Lights Distributors, LLC, Member FINRA/SIPC, which is not affiliated with Eventide Asset Management, LLC.